|
TMOD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.245400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.968600E-01 |
| Normal-vs-Stage2 |
4.560800E-01 |
| Normal-vs-Stage3 |
8.022100E-03 |
| Normal-vs-Stage4 |
5.337900E-02 |
| Stage1-vs-Stage2 |
2.613800E-01 |
| Stage1-vs-Stage3 |
8.938900E-03 |
| Stage1-vs-Stage4 |
6.238100E-02 |
| Stage2-vs-Stage3 |
6.077000E-03 |
| Stage2-vs-Stage4 |
3.171900E-02 |
| Stage3-vs-Stage4 |
9.473400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.326000E-02 |
| Normal-vs-AfricanAmerican |
6.969400E-01 |
| Normal-vs-Asian |
6.632800E-01 |
| Caucasian-vs-AfricanAmerican |
2.395200E-01 |
| Caucasian-vs-Asian |
4.294600E-01 |
| AfricanAmerican-vs-Asian |
5.181400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.203010E-01 |
| Normal-vs-Female |
3.600200E-01 |
| Male-vs-Female |
3.464000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.565400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.341700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.916130E-02 |
| Normal-vs-Age(81-100Yrs) |
9.177200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.655600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.636480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.989400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.015000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.440400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.951200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.180800E-04 |
| Classical-VS-Follicular |
1.215580E-01 |
| Classical-VS-Other |
1.976410E-01 |
| Classical-VS-Normal |
3.810400E-01 |
| Tall-VS-Follicular |
4.13970000000541E-05 |
| Tall-VS-Other |
8.860000E-01 |
| Tall-VS-Normal |
1.176840E-04 |
| Follicular-VS-Other |
1.051240E-01 |
| Follicular-VS-Normal |
5.267200E-01 |
| Other-VS-Normal |
3.635800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.516000E-01 |
| Normal-vs-N1 |
8.532100E-02 |
| N0-vs-N1 |
2.400000E-01 |
|
|
